What is the projected market valuation for the US integrated cardiology-devices market by 2035?

The projected market valuation for the US integrated cardiology-devices market is $992.46 Million by 2035. Read More

What was the market valuation for the US integrated cardiology-devices market in 2024?

The market valuation for the US integrated cardiology-devices market was $454.28 Million in 2024. Read More

What is the expected CAGR for the US integrated cardiology-devices market during the forecast period 2025 - 2035?

The expected CAGR for the US integrated cardiology-devices market during the forecast period 2025 - 2035 is 7.36%. Read More

Which companies are considered key players in the US integrated cardiology-devices market?

Key players in the US integrated cardiology-devices market include Medtronic, Abbott, Boston Scientific, Philips, Johnson & Johnson, Siemens Healthineers, B. Braun, Stryker, and Terumo. Read More

What are the main segments of the US integrated cardiology-devices market?

The main segments of the US integrated cardiology-devices market include Type, Application, and End User. Read More

What was the valuation of the Cardiology EMR Software segment in 2024?

The valuation of the Cardiology EMR Software segment was $90.0 Million in 2024 and is projected to reach $200.0 Million. Read More

How much is the Hospitals segment expected to grow by 2035?

The Hospitals segment is expected to grow from $250.0 Million in 2024 to $600.0 Million by 2035. Read More

What is the projected valuation for the Cardiac resynchronization therapy application by 2035?

The projected valuation for the Cardiac resynchronization therapy application is expected to increase from $68.57 Million in 2024 to $150.0 Million by 2035. Read More

What is the expected growth for the Optical Coherence Tomography segment by 2035?

The Optical Coherence Tomography segment is expected to grow from $50.0 Million in 2024 to $100.0 Million by 2035. Read More

Which end user segment had a valuation of $90.0 Million in 2024?

The catheterization laboratories end user segment had a valuation of $90.0 Million in 2024 and is projected to reach $200.0 Million. Read More

US Integrated Cardiology Devices Market

US Integrated Cardiology Devices Market Research Report: Size, Share, Trend Analysis By Typess (Cardiology EMR Software, EHR, FFR, Optical Coherence Tomography, others), By Applicationss (Sudden Cardiac Arrest, Internal Monitoring, Cardiac Resynchronization Therapy, Cardiothoracic Surgery, others), By End Users (Catheterization Laboratories, Hospitals, others)-Forecast till 2035

Forecast Period

2025 - 2035

CAGR

7.36%

2024 Market Size

$ 454.28 Million

2035 Market Size

$ 992.46 Million

Medical Device ● Updated April 2026 Report ID: MRFR/MED/11579-CR | Pages: 100 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Type (USD Million)
  1. 4.1.1 Cardiology EMR Software
  2. 4.1.2 EHR (Electronic health record)
  3. 4.1.3 FFR (fractional flow reserve)
  4. 4.1.4 Optical Coherence Tomography
  5. 4.1.5 others
2. 4.2 Chemicals and Materials, BY Application (USD Million)
  1. 4.2.1 sudden cardiac arrest
  2. 4.2.2 internal monitoring
  3. 4.2.3 Cardiac resynchronization therapy
  4. 4.2.4 Cardiothoracic surgery
  5. 4.2.5 others
3. 4.3 Chemicals and Materials, BY End User (USD Million)
  1. 4.3.1 catheterization laboratories
  2. 4.3.2 Hospitals
  3. 4.3.3 others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Philips (NL)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Johnson & Johnson (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Siemens Healthineers (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 B. Braun (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Terumo (JP)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF CHEMICALS AND MATERIALS
8. 6.8 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
9. 6.9 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
11. 6.11 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
12. 6.12 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
13. 6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Integrated Cardiology Devices Market Segmentation

US Integrated Cardiology Devices Market By Type (USD Million, 2025-2035)

Cardiology EMR Software
EHR (Electronic health record)
FFR (fractional flow reserve)
Optical Coherence Tomography
others

US Integrated Cardiology Devices Market By Application (USD Million, 2025-2035)

sudden cardiac arrest
internal monitoring
Cardiac resynchronization therapy
Cardiothoracic surgery
others

US Integrated Cardiology Devices Market By End User (USD Million, 2025-2035)

catheterization laboratories
Hospitals
others

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”